MedPath

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

Conditions
Obstructive Sleep Apnea
Registration Number
NCT01683721
Lead Sponsor
ApniCure, Inc.
Brief Summary

The objective of the Study is to observe the use and utility of the Winx Sleep Therapy System in a clinical practice, for the treatment of patients with obstructive sleep apnea (OSA).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Sleep Medicine Associates of Texas (SMAT)

🇺🇸

Dallas, Texas, United States

St. Petersburg Sleep Disorders Center

🇺🇸

St. Petersburg, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath